Agenus (NASDAQ:AGEN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Agenus (AGEN) operate in?

Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Agenus Stock (NASDAQ: AGEN) stock price, news, charts, stock research, profile.

Open	$2.75
Close	$2.83
Volume / Avg.	790.89K / 494.38K
Day Range	$2.66 - $2.91
52 Wk Range	2.50 - 19.69
Market Cap	$66.82M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.75%
Days to Cover	3.97

Recent News

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

Agenus secures a $22M mortgage and announces a strategic realignment to focus on botensilimab/balstilimab in MSS colorectal cancer.

Nabaparna Bhattacharya

GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.

Vandana Singh

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Agenus reports that Bristol Myers Squibb (NYSE: BMY) is ending their 2021 agreement, returning the TIGIT bispecific antibody AGEN1777. This decision is part of Bristol Myers' broader pipeline strategy adjustments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.75
Close	$2.83
Volume / Avg.	790.89K / 494.38K
Day Range	$2.66 - $2.91
52 Wk Range	2.50 - 19.69
Market Cap	$66.82M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.75%
Days to Cover	3.97

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Agenus (AGEN) stock?

You can purchase shares of Agenus (NASDAQ:AGEN) through any online brokerage.

View our list of the best stock brokerages

Who are Agenus (AGEN) competitors?

Other companies in Agenus’s space includes: Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Inovio Pharmaceuticals (NASDAQ:INO), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).

What is the forecast, or price target, for Agenus (AGEN) stock?

Agenus has a consensus price target of $10.23.

What is the current price for Agenus (AGEN)?

The stock price for Agenus (NASDAQ: AGEN) is $2.83 last updated December 20, 2024 at 7:57 PM EST.

Does Agenus (AGEN) pay a dividend?

There are no upcoming dividends for Agenus.

When is Agenus (NASDAQ:AGEN) reporting earnings?

Agenus’s Q4 earnings are confirmed for Thursday, March 13, 2025.

Is Agenus (AGEN) going to split?

There is no upcoming split for Agenus.

What sector and industry does Agenus (AGEN) operate in?

Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Agenus

Agenus (AGEN) Forecast